Product Information
AMITRIPTYLINE HCL 50 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0957 per EA under NDC 72888006900. Its NADAC has been published 64 times since Apr 9, 2025.
Strength
50 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888006900
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215376On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for AMITRIPTYLINE HCL 50 MG TAB has been published 64 times since Apr 9, 2025, and over the history we have for it it has risen 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0957 per EA |
|---|---|
| All-time high | $0.1019 (Jun 10, 2026) |
| All-time low | $0.0859 (Apr 9, 2025) |
| 52-week high | $0.1019 |
| 52-week low | $0.0889 |
| Median price | $0.0940 |
| Average price | $0.0941 |
| Largest weekly change | +8.3% (May 21, 2025) |
| Weeks tracked | 64 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMITRIPTYLINE HCL 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 50 MG TAB, manufactured by Advagen Pharma Ltd., is $0.0957 per EA (NDC 72888006900), effective Jun 24, 2026.
How has the price of AMITRIPTYLINE HCL 50 MG TAB changed over time?
Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 50 MG TAB has risen 11.4%. It has been tracked across 64 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 50 MG TAB?
Since Apr 9, 2025, the NADAC for AMITRIPTYLINE HCL 50 MG TAB has ranged from a low of $0.0859 (Apr 9, 2025) to a high of $0.1019 (Jun 10, 2026), with a median of $0.0940 per EA.
Are there cheaper alternatives to AMITRIPTYLINE HCL 50 MG TAB?
12 NADAC-published products share the same active ingredient, strength, and dosage form as AMITRIPTYLINE HCL 50 MG TAB, but none are currently priced below it.
Who manufactures AMITRIPTYLINE HCL 50 MG TAB?
AMITRIPTYLINE HCL 50 MG TAB (NDC 72888006900) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification